Skip to main content

Table 2 2000 Cohort / OA/RA vs. OA/RA + CVD medications, by age and sex

From: Using clinical trial data and linked administrative health data to reduce the risk of adverse events associated with the uptake of newly released drugs by older Australians: a model process

Age Group OA/RA
drugs only
Male
OA/RA
drugs only
Female
% of patients
taking OA/RA
drugs only
OA/RA plus
CVD drugs
Male
OA/RA plus
CVD drugs
Female
% of patients
taking OA/RA
plus CVD drugs
65-69 2,862 3,272 39% 4,427 5,255 61%
70-74 2,528 2,607 32% 4,999 6,035 68%
75-79 1,707 1,980 28% 4,091 5,535 72%
80-84 854 1,175 26% 2,159 3,648 74%
85-99 491 897 24% 1,327 3,119 76%
Sub-totals 8,442 9,931   17,003 23,592  
  Patient Total = 18,373 Patient Total = 40,595